PMID: 11931724Apr 5, 2002Paper

Painful Peripheral Neuropathy

Current Treatment Options in Neurology
Gil I Wolfe, Richard J Barohn

Abstract

Treatment of neuropathic pain is the primary focus of management for many patients with painful peripheral neuropathies. Neuropathic pain is a common feature of many peripheral neuropathies including those associated with diabetes, uremia, HIV infection, and alcohol abuse. Pain is also present in the majority of patients with idiopathic sensory and sensorimotor polyneuropathies. A growing number of pharmacologic agents are available for the treatment of neuropathic pain. The medications that have undergone the most rigorous study are the tricyclic antidepressants and anticonvulsants. These two families of medications are widely used and represent first-line agents in the management of neuropathic pain. Pain management should begin with a concerted effort to identify the etiology of the neuropathy, as directed therapy may help alleviate the symptoms. When initiating pharmacotherapy for neuropathic pain, one must individualize treatment and choose an agent that is likely to be tolerated, as adverse events are not uncommon for some of the medications. Treatment of neuropathic pain remains challenging, with considerable variability in an individual's response to the various agents and even to different drugs in the same class. Howe...Continue Reading

References

May 7, 1992·The New England Journal of Medicine·M B MaxR Dubner
Nov 19, 1965·Science·R Melzack, P D Wall
Jul 1, 1995·The Annals of Pharmacotherapy·P T Calissi, L A Jaber
Oct 1, 1996·Surgical Neurology·K KumarR K Nath
May 23, 1998·Diabetes Research and Clinical Practice·B B AbuaishaA J Boulton
Oct 10, 1998·Neurologic Clinics·B S Galer
Dec 10, 1998·JAMA : the Journal of the American Medical Association·M BackonjaE Garofalo
May 18, 1999·Archives of Neurology·G I WolfeR J Barohn
Jun 17, 1999·Lancet·C J Woolf, R J Mannion
Nov 24, 1999·Neurology·M I PeriquetJ R Mendell
Mar 31, 2000·The Clinical Journal of Pain·M R Semenchuk, B Davis
Oct 12, 2000·Journal of Pain and Symptom Management·C DallocchioS Chiroli
Nov 4, 2000·Neurology·S H Sindrup, T S Jensen
Nov 19, 2003·The Journal of Pain : Official Journal of the American Pain Society·M R Semenchuk, S Sherman

❮ Previous
Next ❯

Citations

Jun 7, 2007·Experimental Brain Research·Mariano SerraoDario Farina
Aug 11, 2005·Current HIV/AIDS Reports·Susama VermaDavid Simpson
May 15, 2004·Current Infectious Disease Reports·Susama VermaDavid Simpson
Jul 16, 2013·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Xiaobing Shi, Shengyuan Yu
Jul 12, 2007·The Neurologist·Kefah Al-Hayk, Tulio E Bertorini
Jan 31, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·William T WhiteSrinivas Nalamachu
May 7, 2013·Neurologic Clinics·Jaya R TrivediGil I Wolfe
Jun 29, 2004·Muscle & Nerve·Gil I Wolfe, Jaya R Trivedi
Feb 17, 2005·European Journal of Pharmacology·James J LynchPrisca Honore
Mar 7, 2013·The International Journal of Neuroscience·Mamatha PasnoorRichard Barohn
Apr 6, 2006·Journal of Neurovirology·Barry RobinsonAvindra Nath
Aug 1, 2015·Reviews in the Neurosciences·Judyta JuranekVivek Rai

❮ Previous
Next ❯

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.